Development and characterisation of lyophilised ethambutol-loaded polymeric nanoparticles
DOI:
https://doi.org/10.69857/joapr.v13i2.1093Keywords:
Ethambutol, Poly-ℇ-caprolactone, Lyophilization, Sustained release, TuberculosisAbstract
Background: Tuberculosis (TB) remains a universal health crisis, requiring innovative drug delivery systems to overcome challenges like prolonged treatment duration and patient non-adherence. This study was designed to develop Ethambutol (ETH)-loaded poly-ε-caprolactone (PCL) nanoparticles (NPs) as a sustained-release pulmonary delivery platform for TB therapy. Methodology: ETH-PCL NPs were fabricated using the nanoprecipitation technique with Lutrol® F68 as a stabiliser. The formulation was optimised for physicochemical properties (particle size, polydispersity index (PDI), zeta potential), encapsulation efficiency (EE), and morphology (SEM). In vitro drug release and 3-month colloidal stability were evaluated. Results and Discussion: The optimised NPs exhibited a rod-shaped morphology with smooth surfaces, an average size of 426.3 ± 13.03 nm, PDI < 0.467, zeta potential of -18.8 ± 0.520 mV, and EE of 76.57±3.86%. Sustained ETH release (86.62% over 24 h) and robust colloidal stability (negligible changes in size, PDI, and zeta potential over 3 months) were achieved. The formulation's biodegradable PCL core and scalable design align with the need for cost-effective, patient-centric therapies. Conclusion: ETH-PCL NPs represent a promising nanocarrier platform for TB, combining sustained drug release, high encapsulation efficiency, and long-term stability. While in vitro results are encouraging, future studies must validate in vivo efficacy and pulmonary delivery potential. This work underscores the viability of nanotechnology in addressing TB treatment challenges, particularly in improving adherence and targeting mycobacteria-laden macrophages.
Downloads
References
Bahlool AZ, Cavanagh B, Sullivan AO, MacLoughlin R, Keane J, Sullivan MPO, Cryan SA. Microfluidics produced ATRA-loaded PLGA NPs reduced tuberculosis burden in alveolar epithelial cells and enabled high delivered dose under simulated human breathing pattern in 3D printed head models. Eur. J. Pharm. Sci., 196, 106734 (2024) https://doi.org/10.1016/j.ejps.2024.106734.
Sefat KMSR, Kumar M, Kehl S, Kulkarni R, Leekha A, Paniagua MM, Ackart DF, Jones N, Spencer C, Podell BK, Ouellet H, Varadarajan N. An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine, 42, (2024) https://doi.org/10.1016/j.vaccine.2024.04.055.
Estaji F, Kamali A, Keikha M. Strengthening the global Response to Tuberculosis: Insights from the 2024 WHO global TB report. J Clin Tuberc Other Mycobact Dis, 39, 100522 (2025) https://doi.org/10.1016/j.jctube.2025.100522
Chee CBE, Reves R, Zhang Y, Belknap R. Latent tuberculosis infection: Opportunities and challenges. Respirology, 23, 893–900 (2018) https://doi.org/10.1111/resp.13346.
Mobed A, Alivirdiloo V, Gholami S, Moshari A, Mousavizade A, Naderian R, Ghazi F. Nano-Medicine for Treatment of Tuberculosis, Promising Approaches Against Antimicrobial Resistance. Curr. Microbiol., 81, 1–15 (2024) https://doi.org/10.1007/s00284-024-03853-z.
Patil SM, Diorio AM, Kommarajula P, Kunda NK. A quality-by-design strategic approach for the development of bedaquiline-pretomanid nanoparticles as inhalable dry powders for TB treatment. Int. J. Pharm., 653, 123920 (2024) https://doi.org/10.1016/j.ijpharm.2024.123920.
Fekadu G, Bekele F, Bekele K, Girma T, Mosisa G, Gebre M, Alemu T, Tekle T, Gamachu B, Diriba A. Adherence to Anti-Tuberculosis Treatment Among Pediatric Patients at Nekemte Specialized Hospital, Western Ethiopia. Patient Prefer. Adherence, Volume 14, 1259–65 (2020) https://doi.org/10.2147/PPA.S258292.
Bea S, Lee H, Kim JH, Jang SH, Son H, Kwon J-W, Shin J-Y. Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients. Front. Pharmacol., 12, (2021) https://doi.org/10.3389/fphar.2021.625078.
Jadhav K, Kole E, Abhang A, Rojekar S, Sugandhi V, Verma RK, Mujumdar A, Naik J. Revealing the potential of nano spray drying for effective delivery of pharmaceuticals and biologicals. Dry. Technol., 1–24 (2024) https://doi.org/10.1080/07373937.2024.2437691.
Pardeshi SR, Kole EB, Kapare HS, Chandankar SM, Shinde PJ, Boisa GS, Salgaonkar SS, Giram PS, More MP, Kolimi P, Nyavanandi D, Dyawanapelly S, Junnuthula V. Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations. Pharmaceutics, 14, 2632 (2022) https://doi.org/10.3390/pharmaceutics14122632.
Kole E, Jadhav K, Shirsath N, Dudhe P, Verma RK, Chatterjee A, Naik J. Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases. J. Drug Deliv. Sci. Technol., 81, 104261 (2023) https://doi.org/10.1016/j.jddst.2023.104261.
Jadhav K, Kole E, Singh R, Rout SK, Verma RK, Chatterjee A, Mujumdar A, Naik J. A critical review on developments in drying technologies for enhanced stability and bioavailability of pharmaceuticals. Dry. Technol., 42, 1415–41 (2024) https://doi.org/10.1080/07373937.2024.2357181.
Kole E, Jadhav K, Sonar Y, Kapse M, Patil SA, Kumar A. Advances in spray drying technology for anti-tubercular formulation development : A comprehensive review. Dry. Technol., 0, 1–37 (2025) https://doi.org/10.1080/07373937.2024.2437690.
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres M del P, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S, Shin H-S. Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnology, 16, 71 (2018) https://doi.org/10.1186/s12951-018-0392-8.
Kumar M, Virmani T, Kumar G, Deshmukh R, Sharma A, Duarte S, Brandão P, Fonte P. Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies. Pharmaceuticals, 16, 1360 (2023) https://doi.org/10.3390/ph16101360.
Begines B, Ortiz T, Pérez-Aranda M, Martínez G, Merinero M, Argüelles-Arias F, Alcudia A. Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects. Nanomaterials, 10, 1403 (2020) https://doi.org/10.3390/nano10071403.
Eltaib L. Polymeric Nanoparticles in Targeted Drug Delivery: Unveiling the Impact of Polymer Characterization and Fabrication. Polymers (Basel)., 17, 833 (2025) https://doi.org/10.3390/polym17070833.
Opriș O, Mormile C, Lung I, Stegarescu A, Soran M-L, Soran A. An Overview of Biopolymers for Drug Delivery Applications. Appl. Sci., 14, 1383 (2024) https://doi.org/10.3390/app14041383.
Tsung T-H, Tsai Y-C, Lee H-P, Chen Y-H, Lu D-W. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases. Int. J. Mol. Sci., 24, 12976 (2023) https://doi.org/10.3390/ijms241612976.
Alimohammadi M, Fakhraei O, Moradi A, Kabiri M, Moradi A, Passandideh-Fard M, Tamayol A, Ebrahimzadeh MH, Mousavi Shaegh SA. Controlled release of azithromycin from polycaprolactone/chitosan nanofibrous membranes. J. Drug Deliv. Sci. Technol., 71, 103246 (2022) https://doi.org/10.1016/j.jddst.2022.103246.
Kole E, Jadhav K, Khan Z, Verma RK, Chatterjee A, Mujumdar A, Naik J. Engineered vildagliptin-loaded polymeric nanoparticles via microfluidic and spray drying for enhanced antidiabetic activity. Futur. J. Pharm. Sci., 10, 156 (2024) https://doi.org/10.1186/s43094-024-00736-9.
Sun H, Mei L, Song C, Cui X, Wang P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials, 27, 1735–40 (2006) https://doi.org/10.1016/j.biomaterials.2005.09.019.
Patil A, Pardeshi S, Kapase M, Patil P, More M, Dhole S, Kole E, Deshmukh P, Gholap A, Mujumdar A, Naik J. Continuous preparation of sustained release vildagliptin nanoparticles using tubular microreactor approach. Dry. Technol., 1–13 (2024) https://doi.org/10.1080/07373937.2023.2298778.
Guo P, Buttaro BA, Xue HY, Tran NT, Wong HL. Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms. Eur. J. Pharm. Biopharm., 151, 189–98 (2020) https://doi.org/10.1016/j.ejpb.2020.04.010.
Mandpe S, Kole E, Parate V, Chatterjee A, Mujumdar A, Naik J. Development, QbD-based optimisation, in-vivo pharmacokinetics, and ex-vivo evaluation of Eudragit ® RS 100 loaded flurbiprofen nanoparticles for oral drug delivery. J. Microencapsul., 1–13 (2024) https://doi.org/10.1080/02652048.2024.2427294.
Khairnar G, Mokale V, Khairnar R, Mujumdar A, Naik J. Production of antihyerglycemic and antihypertensive drug loaded sustained release nanoparticles using spray drying technique: Optimization by Placket Burman Design. Dry. Technol., 40, 626–37 (2022) https://doi.org/10.1080/07373937.2020.1825292.
Mandpe S, Kole E, Parate V, Chatterjee A, Mujumdar A, Naik J. Design, development, and evaluation of spray dried flurbiprofen loaded sustained release polymeric nanoparticles using QBD approach to manage inflammation. Dry. Technol., 1–13 (2023) https://doi.org/10.1080/07373937.2023.2251572.
Mandpe S, Kole E, Parate V, Chatterjee A, Mujumdar A, Naik J. Development, QbD-based optimisation, in-vivo pharmacokinetics, and ex-vivo evaluation of Eudragit ® RS 100 loaded flurbiprofen nanoparticles for oral drug delivery. J. Microencapsul., 0, 1–13 (2024) https://doi.org/10.1080/02652048.2024.2427294.
Jiang Y, Zhou Y, Zhang CY, Fang T. Co-delivery of paclitaxel and doxorubicin by ph-responsive prodrug micelles for cancer therapy. Int. J. Nanomedicine, 15, 3319–31 (2020) https://doi.org/10.2147/IJN.S249144.
Verma U, Mujumdar A, Naik J. Preparation of Efavirenz resinate by spray drying using response surface methodology and its physicochemical characterization for taste masking. Dry. Technol., 38, 793–805 (2020) https://doi.org/10.1080/07373937.2019.1590845.
Wagh P, Mujumdar A, Naik JB. Preparation and characterization of ketorolac tromethamine-loaded ethyl cellulose micro-/nanospheres using different techniques. Part. Sci. Technol., 37, 347–57 (2019) https://doi.org/10.1080/02726351.2017.1383330.
Diwan R, Ravi PR, Agarwal SI, Aggarwal V. Cilnidipine loaded poly (ε-caprolactone) nanoparticles for enhanced oral delivery: optimization using DoE, physical characterization, pharmacokinetic, and pharmacodynamic evaluation. Pharm. Dev. Technol., 26, 278–90 (2021) https://doi.org/10.1080/10837450.2020.1864643.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Eknath Kole, Yogesh Sonar, Rahul J. Sarode, Atul Chaudhari, Jitendra Naik
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
